Florida: UF working on state funded research on low-THC medical marijuana

The University of Florida is moving forward with two state-funded research initiatives on low-THC medical marijuana systems lawmakers approved in 2014.

This week, the Florida Department of Health announced its approval of $1 million for a team led by UF Health Shands pediatric neurologist Dr. Paul Carney to treat up to 50 children who have drug resistant epilepsy with a minimal-THC content, cannabidiol-rich oral solution called Epidiolex.

That study will recruit participants in Gainesville and across the state at several other hospitals and focus on children ages 2-16 whose seizures have not been controlled by other anti-epileptic drugs.

The University of Florida College of Pharmacy is also in talks with the Department of Health to complete an agreement for the College of Pharmacy to develop a database registry of patients and providers in the low-THC noneuphoric medical marijuana system. That database will include registration information on patients and providers, provider...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.